Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Cochlear Baha 5 SuperPower Sound Processor on the Baha Attract System

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02722330
Recruitment Status : Completed
First Posted : March 30, 2016
Results First Posted : June 3, 2019
Last Update Posted : June 3, 2019
Sponsor:
Information provided by (Responsible Party):
Cochlear Bone Anchored Solutions

Brief Summary:
The aim of this clinical investigation is to evaluate objective and subjective hearing performance with the Cochlear Baha 5 SuperPower Sound Processor on the Baha Attract System, compared to the unaided hearing performance. Comparison of audiological test results with the same sound processor on a Baha Softband will also be performed. Short term safety parameters will be collected.

Condition or disease Intervention/treatment Phase
Single Sided Sensorineural Deafness Mixed Hearing Loss, Unilateral Device: Baha 5 SuperPower on Baha Attract System Not Applicable

Detailed Description:

The Cochlear Baha bone conduction hearing implant offers two alternative ways to transmit vibrations from the external sound processor to the osseointegrated implant: The Baha Connect System uses a skin-penetrating abutment and allows direct bone conduction. The Baha Attract System uses a magnetic connection through intact skin. Magnetic bone conduction hearing implants have the advantage over skin-penetrating systems of eliminating the daily cleaning of the site and are perceived as a more cosmetically appealing by some subjects. With modern sound processor technology, it is possible to obtain good sound transmission despite the soft tissue attenuation that is inherent to magnetic bone conduction hearing implants. Clinical investigations have shown that the Baha Attract System, when used in combination with existing head-worn sound processors within the Premium (e.g. BP100, Baha 4 Sound Processors) and Power (BP110 Sound processor) segments, provides good hearing outcomes in subjects with conductive and mild mixed hearing loss.

The Cochlear Baha 5 SuperPower Sound Processor is the first head-worn sound processor within the Super Power segment and has a fitting range of 65 dBHL. It is CE marked and is intended for subjects with mixed hearing loss or single-sided sensorineural deafness (SSD). It can be used with the Baha Connect and Baha Attract Systems and with a Baha Softband. When used in combination with the Baha Attract System, it will be able to compensate for a larger sensorineural component than the current Premium and Power sound processors and, hence, will allow more subjects to benefit from the Baha Attract System. The combination Baha Attract System with Baha 5 SuperPower Sound Processor is the most powerful non-skin penetrating bone conduction hearing implant solution available today.

The Baha 5 SuperPower Sound Processor includes discreet design, advanced signal processing and improved connectivity to external sound sources. The new sound processor supports Cochlear's 2.4 GHz wireless protocol and is programmable with a new version of the Baha 5 Fitting Software.

The aim of this clinical investigation is to evaluate objective and subjective hearing performance with the Cochlear Baha 5 SuperPower Sound Processor on the Baha Attract System, compared to the unaided hearing performance. Comparison of audiological test results with the same sound processor on a Baha Softband will also be performed. Short term safety parameters will be collected.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 23 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Evaluation of Audiological Outcomes and Subjective Benefits of Cochlear Baha® 5 SuperPower Sound Processor on the Baha® Attract™ System
Study Start Date : April 2016
Actual Primary Completion Date : December 2016
Actual Study Completion Date : December 2016

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Baha 5 SuperPower on Baha Attract System

The device involves the following parts:

The sound processor unit, an actuator unit and a cable, the Sound Processor Magnet (SP Magnet) of the Baha Attract System, the BIM400 Baha Implant Magnet that is fixated to the BI300 Implant, a snap coupling.

Device: Baha 5 SuperPower on Baha Attract System
The Investigational device involves the following parts: the sound processor unit, an actuator unit and a cable that connects the sound processor and actuator units. The actuator unit is attached to the Sound Processor Magnet (SP Magnet) of the Baha Attract System which is pulled towards the BIM400 Baha Implant Magnet that is fixated to the BI300 Implant. The actuator unit can also be connected to the Baha Softband via a snap coupling.




Primary Outcome Measures :
  1. Audiometry; Free Field Thresholds. Pure Tone Average PTA4,Unaided vs Aided [ Time Frame: 12 weeks ]
    Change of hearing performance PTA4 [Mean of 0.5, 1, 2 and 4 kHz] from the unaided hearing situation at pre-operation with the Investigational device on the attract system, aided at 12 weeks


Secondary Outcome Measures :
  1. Change of the Self-reported Assessments of Hearing Outcome Using Abbreviated Profile of Hearing Aid Benefit (APHAB) From the Unaided Hearing Situation at Pre-operation With the Investigational Device on the Attract System, at 12 Weeks. [ Time Frame: 12 weeks ]

    The APHAB is a 24-item self-assessment questionnaire evaluating the benefit experienced by the subject when using hearing amplification compared to the unaided situation. It comprises of four subscales: Ease of Communication (EC), Reverberation (RV), Background Noise (BN), and Aversiveness (AV). The Global score is the mean of the subscales. All subscales are scored in the same way.

    The scores show how frequently (%) clients experience performance problems and varies between 0-100, 0 indicates no problems, 100 indicates always problem. Benefit is then calculated by subtracting the aided average from the unaided average. The theoretical benefit score could vary between -100 to + 100. The higher the score the better benefit and positive score indicates an improvement, a negative value an impairment.


  2. Change of the Self-reported Assessments of Hearing Outcome Using Speech, Spatial and Qualities of Hearing Scale (SSQ-12) From the Unaided Hearing Situation at Pre-operation With the Investigational Device on the Attract System, Aided at 12 Weeks. [ Time Frame: 12 weeks ]

    The SSQ-12 is comprised of 12 items using the response format on a scale from 0 to 10, were 0 equals no ability and 10 equals perfect ability. These are divided into three sub-scales and the questions 1-5 are from the speech sub-scale, 6-8 from the spatial, and 9-12 from the qualities sub-scale. The three sub-scales are the average of the questions within. A 'not applicable' option is given for each item.

    The change from unaided to aided hearing is then calculated and the theoretical score could vary between -10 to + 10. The higher the score the better benefit and positive score indicates improved hearing, a negative value an impaired hearing.


  3. Audiometry; Free Field Thresholds. Pure Tone Average PTA4 Unaided vs Aided [ Time Frame: 4 weeks ]
    Change of hearing performance PTA4 [Mean of 0.5, 1, 2 and 4 kHz] from the unaided hearing situation at pre-operation with the Investigational device on the attract system, aided at 4 weeks

  4. Audiometry; Free Field Thresholds Per Frequency, Unaided vs Aided [ Time Frame: 4 weeks ]
    Change of hearing performance free field tresholds per frequency [0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0 kHz] from unaided hearing situation at pre-operation with the Investigational device on the attract system, aided at 4 weeks

  5. Audiometry; Free Field Thresholds Per Frequency, Unaided vs Aided [ Time Frame: 12 weeks ]
    Change of hearing performance free field tresholds per frequency [0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0 kHz] from unaided hearing situation at pre-operation with the Investigational device on the attract system, aided at 12 weeks

  6. Free Field; - Adaptive Speech Recognition in Noise, Unaided vs Aided [ Time Frame: 4 weeks ]
    Change of hearing performance free field - adaptive speech recognition in noise from unaided hearing situation at pre-operation with the Investigational device on the attract system, aided at 4 weeks

  7. Free Field; - Adaptive Speech Recognition in Noise, Unaided vs Aided [ Time Frame: 12 weeks ]
    Change of hearing performance free field - adaptive speech recognition in noise from unaided hearing situation at pre-operation with the Investigational device on the attract system, aided at 12 weeks

  8. Free Field; - Speech Recognition in Quiet, Unaided vs Aided [ Time Frame: 4 weeks ]
    Change of hearing performance free field - speech recognition in quiet from the unaided hearing situation at pre-operation with the Investigational device on the attract system, aided at 4 weeks

  9. Free Field; - Speech Recognition in Quiet, Unaided vs Aided [ Time Frame: 12 weeks ]
    Change of hearing performance free field - speech recognition in quiet from the unaided hearing situation at pre-operation with the Investigational device on the attract system, aided at 12 weeks

  10. Audiometry; Free Field Thresholds. Pure Tone Average PTA4, Investigational Device vs Softband [ Time Frame: 4 weeks ]
    Change of hearing performance PTA4 [Mean of 0.5, 1, 2 and 4 kHz] from the situation with the same sound processor on a Baha soft band at pre-operation with the Investigational device on the attract system at 4 weeks

  11. Audiometry; Free Field Thresholds. Pure Tone Average PTA4 [Mean of 0.5, 1, 2 and 4 kHz], Investigational Device vs Softband [ Time Frame: 12 weeks ]
    Change of hearing performance PTA4 from the situation with the same sound processor on a Baha soft band at pre-operation with the Investigational device on the attract system at 12 weeks

  12. Audiometry; Free Field Thresholds Per Frequency, Investigational Device vs Softband [ Time Frame: 4 weeks ]
    Change of hearing performance free field tresholds per frequency [0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0 kHz] from the situation with same sound processor on a Baha softband with the Investigational device on the attract system at 4 weeks

  13. Audiometry; Free Field Thresholds Per Frequency, Investigational Device vs Softband [ Time Frame: 12 weeks ]
    Change of hearing performance free field tresholds per frequency [0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0 kHz] from the same sound processor on a Baha softband with the Investigational device on the attract system at 12 weeks

  14. Free Field - Adaptive Speech Recognition in Noise, Investigational Device vs Softband [ Time Frame: 4 weeks ]
    Change of hearing performance free field - adaptive speech recognition in noise from the situation with the same sound processor on a Baha softband at pre-operation with the Investigational device on the attract system at 4 weeks

  15. Free Field - Adaptive Speech Recognition in Noise, Investigational Device vs Softband [ Time Frame: 12 weeks ]
    Change of hearing performance free field - adaptive speech recognition in noise from the situation with the same sound processor on a Baha softband at pre-operation with the Investigational device on the attract system at 12 weeks

  16. Free Field - Speech Recognition in Quiet, Investigational Device vs Softband [ Time Frame: 4 weeks ]
    Change of hearing performance free field - speech recognition in quiet from the situation with the same sound processor on a Baha Softband with the Investigational device on the attract system at 4 weeks

  17. Free Field - Speech Recognition in Quiet, Investigational Device vs Softband [ Time Frame: 12 weeks ]
    Change of hearing performance free field - speech recognition in quiet from the situation with the same sound processor on a Baha Softband with the Investigational device on the attract system at 12 weeks

  18. Sound Processor Magnet Selection at 4 Weeks [ Time Frame: 4 weeks ]
    Information about sound processor magnet selection, type of SP magnet

  19. Sound Processor Magnet Selection at 6 Weeks [ Time Frame: 6 weeks ]
    Information about sound processor magnet selection, type of SP magnet

  20. Sound Processor Magnet Selection at 12 Weeks [ Time Frame: 12 weeks ]
    Information about sound processor magnet selection, type of SP magnet

  21. Daily Use of Sound Processor (Average Daily Use During the Last Week) [ Time Frame: 12 weeks ]
    Average daily use (hours/day) of the sound processor during the last week of the study


Other Outcome Measures:
  1. Number of Adverse Events Related to the Treatment [ Time Frame: 12 weeks ]
    Number of adverse events related to the treatment during the 12 weeks treatment period



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adult subjects ≥ 18 years of age
  • Mixed hearing loss in the ear to be implanted. Bone conduction thresholds with pure tone average (PTA4, Mean of 0.5, 1, 2 and 4kHz) of 30-55 dBHL or
  • Single-sided sensorineural deafness: Bone conduction thresholds with a pure tone average [PTA4, Mean of 0.5, 1, 2 and 4 kHz] of lower or 30 dBHL in the best ear. Subjects who have, for some reason, experienced no or limited benefit from other sound processors when tested on a Baha Softband.
  • Subjects suitable for surgery according to the recommended surgical procedure for Cochlear Baha 5 SuperPower with no previous implant on the side to be investigated.
  • Signed inform consent.

Exclusion Criteria:

  • Subject scheduled for simultaneous bilateral implant surgery. The investigation is limited to subjects with unilateral use of the Investigational device (however, bilateral hearing loss is not an exclusion criterion).
  • Suitable implant position for the BI300 Implant (4 mm or 3 mm) not found during surgery due to insufficient bone quality and/or bone thickness
  • Less than 3 mm soft tissue thickness at the planned implant site. (Intra-operative exclusion criteria judged by the surgeon at Visit 1 or Visit 2 according to local practice).
  • Subjects that have received radiation therapy at the same side of the skull where the Investigational device will be positioned.
  • Uncontrolled diabetes as judged by the investigator.
  • Condition that could jeopardise osseointegration and/or wound healing (e.g. osteoporosis, psoriasis and long-term systemic use of corticosteroids) or condition that may have an impact on the outcome of the investigation as judged by the investigator.
  • Unable to follow investigational procedures, e.g. to complete quality of life scales.
  • Participation in another clinical investigation with pharmaceutical and/or device.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02722330


Locations
Layout table for location information
Belgium
Antwerp University Hospital
Antwerp, Belgium
Denmark
Odense University Hospital
Odense, Denmark
Spain
Hospital de Sant Pau
Barcelona, Spain
United Kingdom
Royal Hallamshire Hospital
Sheffield, United Kingdom
Sponsors and Collaborators
Cochlear Bone Anchored Solutions
Investigators
Layout table for investigator information
Principal Investigator: Jaydip Ray, Professor Royal Hallamshire Hospital
Principal Investigator: César Orús, Dr Hospital de Sant Pau
Principal Investigator: Paul Van de Heyning, Professor University Hospital, Antwerp
Principal Investigator: Jesper Schmidt, Dr Odense University Hospital

Layout table for additonal information
Responsible Party: Cochlear Bone Anchored Solutions
ClinicalTrials.gov Identifier: NCT02722330     History of Changes
Other Study ID Numbers: CBAS5619
First Posted: March 30, 2016    Key Record Dates
Results First Posted: June 3, 2019
Last Update Posted: June 3, 2019
Last Verified: February 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Additional relevant MeSH terms:
Layout table for MeSH terms
Hearing Loss
Deafness
Hearing Loss, Mixed Conductive-Sensorineural
Hearing Loss, Unilateral
Hearing Loss, Sensorineural
Hearing Disorders
Ear Diseases
Otorhinolaryngologic Diseases
Sensation Disorders
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms